Hillsdale Investment Management Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1368465 Toronto, A6

Position in HALO

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$7,112,531

-$118,854 QoQ

Shares Held

110,050

+2.4% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $85,671,146 across 25 Biotechnology names. HALO ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	167,742	$12,456,520
2	AXSM	Axsome Therapeutics, Inc.	53,363	$9,019,414
3	ZYME	Zymeworks Inc.	345,622	$8,654,374
4	HALO	Halozyme Therapeutics, Inc. This page	110,050	$7,112,531
5	MIRM	Mirum Pharmaceuticals, Inc.	59,730	$5,517,857
6	ENTA	Enanta Pharmaceuticals Inc	435,510	$5,500,491
7	TVTX	Travere Therapeutics, Inc.	182,320	$5,416,727
8	IONS	Ionis Pharmaceuticals Inc	70,900	$5,323,881

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,112,531	110,050	+2.4%	Shares	Sole	2026-05-04
2025-12-31	$7,231,385	107,450	+14.3%	Shares	Sole	2026-02-10
2025-09-30	$6,893,960	94,000	-0.4%	Shares	Sole	2025-11-10
2025-06-30	$4,910,688	94,400	-3.7%	Shares	Sole	2025-08-12
2025-03-31	$6,253,380	98,000	-7.7%	Shares	Sole	2025-05-09
2024-12-31	$5,077,422	106,200	+0.1%	Shares	Sole	2025-02-11
2024-09-30	$6,073,164	106,100	-2.1%	Shares	Sole	2024-11-12
2024-06-30	$5,675,824	108,400	-4.0%	Shares	Sole	2024-08-13
2024-03-31	$4,592,772	112,900	+45.1%	Shares	Sole	2024-05-10
2021-03-31	$3,243,482	77,800	+1.0%	Shares	Sole	2021-04-22
2020-12-31	$3,288,670	77,000	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.